1. Home
  2. AMRN
  3. AMRN News

Latest Amarin Corporation plc (AMRN) News on November 25, 2025

AMRN

MT Newswires

6 days ago

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

AMRN

MT Newswires

7 days ago

European Equities Traded in the US as American Depositary Receipts Down Sharply in Friday Trading

AMRN

MT Newswires

12 days ago

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading

AMRN

MT Newswires

14 days ago

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

AMRN

MT Newswires

15 days ago

European Equities Traded in the US as American Depositary Receipts Start Week Trending Higher in Monday Trading

New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients
AMRN

GlobeNewswire

16 days ago

New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients

AMRN

MT Newswires

19 days ago

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025
AMRN

GlobeNewswire

22 days ago

Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025

Amarin Corporation plc (NASDAQ:AMRN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$11.33
AMRN

Simply Wall St.

24 days ago

Amarin Corporation plc (NASDAQ:AMRN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$11.33

AMRN

MT Newswires

25 days ago

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

Amarin (AMRN): Deep Discount Reinforces Market Caution Despite Projected Earnings Growth
AMRN

Simply Wall St.

25 days ago

Amarin (AMRN): Deep Discount Reinforces Market Caution Despite Projected Earnings Growth

Amarin Corp PLC (AMRN) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic ...
AMRN

GuruFocus.com

a month ago

Amarin Corp PLC (AMRN) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic ...

Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down
AMRN

Zacks

a month ago

Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down

AMRN

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

AMRN

Associated Press Finance

a month ago

Amarin: Q3 Earnings Snapshot

Amarin Reports Third Quarter 2025 Financial Results
AMRN

GlobeNewswire

a month ago

Amarin Reports Third Quarter 2025 Financial Results

Do Options Traders Know Something About Amarin Stock We Don't?
AMRN

Zacks

a month ago

Do Options Traders Know Something About Amarin Stock We Don't?

Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025
AMRN

GlobeNewswire

a month ago

Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025

AMRN

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Edge Lower Tuesday

AMRN

MT Newswires

a month ago

HLS Therapeutics and Amarin to Present Scientific Data at Cardiovascular Congress

HLS Therapeutics and Amarin Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
AMRN

CNW Group

a month ago

HLS Therapeutics and Amarin Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress

Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
AMRN

GlobeNewswire

a month ago

Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress

AMRN

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

AMRN

MT Newswires

2 months ago

European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

AMRN

MT Newswires

2 months ago

European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading

AMRN

MT Newswires

2 months ago

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains?
AMRN

Zacks

2 months ago

Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains?

AMRN

MT Newswires

2 months ago

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Up 3.3% for Week

AMRN

MT Newswires

4 months ago

European Equities Traded in the US as ADRs Edge Up in Monday Trading

Take the Zacks Approach to Beat the Markets: Amarin, Mogo, 3M in Focus
AMRN

Zacks

4 months ago

Take the Zacks Approach to Beat the Markets: Amarin, Mogo, 3M in Focus

AMRN

MT Newswires

5 months ago

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Up 2.5% for Week

Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU
AMRN

Zacks

5 months ago

Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU

AMRN

MT Newswires

5 months ago

European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading

Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag
AMRN

Zacks

5 months ago

Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag

Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock?
AMRN

Zacks

5 months ago

Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock?

AMRN

MT Newswires

5 months ago

Sector Update: Health Care Stocks Advance Late Afternoon

AMRN

MT Newswires

5 months ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

AMRN

MT Newswires

5 months ago

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

AMRN

MT Newswires

5 months ago

Update: Amarin Signs Licensing Deal With Recordati for Vazkepa in Europe; Shares Rise

AMRN

MT Newswires

5 months ago

Amarin Signs Licensing Deal With Recordati for Vazkepa in Europe

RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE
AMRN

GlobeNewswire

5 months ago

RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE

Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe
AMRN

GlobeNewswire

5 months ago

Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe

Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma
AMRN

Zacks

5 months ago

Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma

Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?
AMRN

Zacks

5 months ago

Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
AMRN

Zacks

5 months ago

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock?
AMRN

Zacks

5 months ago

Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock?

Best Momentum Stocks to Buy for June 10th
AMRN

Zacks

5 months ago

Best Momentum Stocks to Buy for June 10th

Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year?
AMRN

Zacks

6 months ago

Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year?

Earnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Boosting Their Estimates
AMRN

Simply Wall St.

6 months ago

Earnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Boosting Their Estimates

Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y
AMRN

Zacks

7 months ago

Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y

Amarin First Quarter 2025 Earnings: Misses Expectations
AMRN

Simply Wall St.

7 months ago

Amarin First Quarter 2025 Earnings: Misses Expectations

Amarin Corp PLC (AMRN) Q1 2025 Earnings Call Highlights: Strategic Global Expansion Amidst ...
AMRN

GuruFocus.com

7 months ago

Amarin Corp PLC (AMRN) Q1 2025 Earnings Call Highlights: Strategic Global Expansion Amidst ...

AMRN

Associated Press Finance

7 months ago

Amarin: Q1 Earnings Snapshot

Amarin Reports First Quarter 2025 Financial Results
AMRN

GlobeNewswire

7 months ago

Amarin Reports First Quarter 2025 Financial Results

AMRN

GuruFocus.com

7 months ago

Standex International Corp (SXI) Q3 2025 Earnings Call Highlights: Record Margins and Strategic ...

Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
AMRN

GlobeNewswire

7 months ago

Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
AMRN

GlobeNewswire

7 months ago

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025

Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
AMRN

GlobeNewswire

8 months ago

Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change

Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors
AMRN

GlobeNewswire

8 months ago

Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors

Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist
AMRN

GlobeNewswire

8 months ago

Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist

AMRN

MT Newswires

8 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

AMRN

MT Newswires

8 months ago

Amarin Shareholders Calls for Strategic Review

New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
AMRN

GlobeNewswire

8 months ago

New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

AMRN's Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan
AMRN

Zacks

8 months ago

AMRN's Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ...
AMRN

GuruFocus.com

8 months ago

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ...

Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript
AMRN

Motley Fool

8 months ago

Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript

AMRN

MT Newswires

8 months ago

Amarin Plans 1-for-20 ADS Ratio Adjustment

AMRN

Associated Press Finance

8 months ago

Amarin: Q4 Earnings Snapshot

Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program
AMRN

GlobeNewswire

8 months ago

Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program

Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action
AMRN

GlobeNewswire

8 months ago

Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action

Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering
AMRN

GlobeNewswire

9 months ago

Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering

Amarin Receives National Reimbursement for VAZKEPA® in Austria
AMRN

GlobeNewswire

9 months ago

Amarin Receives National Reimbursement for VAZKEPA® in Austria

Here's Why We're Not Too Worried About Amarin's (NASDAQ:AMRN) Cash Burn Situation
AMRN

Simply Wall St.

9 months ago

Here's Why We're Not Too Worried About Amarin's (NASDAQ:AMRN) Cash Burn Situation

Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025
AMRN

GlobeNewswire

9 months ago

Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025

Amarin Receives National Reimbursement for VAZKEPA® in Italy
AMRN

GlobeNewswire

a year ago

Amarin Receives National Reimbursement for VAZKEPA® in Italy

AMRN

MT Newswires

a year ago

Amarin Names Peter Fishman as CFO

Amarin Appoints Peter Fishman Chief Financial Officer
AMRN

GlobeNewswire

a year ago

Amarin Appoints Peter Fishman Chief Financial Officer

After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)
AMRN

Zacks

a year ago

After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)

Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual Scientific Sessions
AMRN

GlobeNewswire

a year ago

Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual Scientific Sessions

Amarin Corp PLC (AMRN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines Amid ...
AMRN

GuruFocus.com

a year ago

Amarin Corp PLC (AMRN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines Amid ...

Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates
AMRN

Zacks

a year ago

Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates

Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript
AMRN

Motley Fool

a year ago

Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript

AMRN

Associated Press Finance

a year ago

Amarin: Q3 Earnings Snapshot

Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update
AMRN

GlobeNewswire

a year ago

Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update

Amarin Corp PLC (AMRN) Q3 2024 Earnings Report Preview: What To Look For
AMRN

GuruFocus.com

a year ago

Amarin Corp PLC (AMRN) Q3 2024 Earnings Report Preview: What To Look For

Amarin Corp PLC (AMRN) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
AMRN

GuruFocus.com

a year ago

Amarin Corp PLC (AMRN) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...

AMRN

MT Newswires

a year ago

Opthea Names Medical Chief, CFO

Amarin Announces Two Upcoming Investor Events
AMRN

GlobeNewswire

a year ago

Amarin Announces Two Upcoming Investor Events

Here's Why We're Not At All Concerned With Amarin's (NASDAQ:AMRN) Cash Burn Situation
AMRN

Simply Wall St.

a year ago

Here's Why We're Not At All Concerned With Amarin's (NASDAQ:AMRN) Cash Burn Situation

Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual European Association for the Study of Diabetes (EASD) Meeting
AMRN

GlobeNewswire

a year ago

Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual European Association for the Study of Diabetes (EASD) Meeting

Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress
AMRN

GlobeNewswire

a year ago

Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress

Exploring 3 Undervalued Small Caps In United States With Insider Action
AMRN

Simply Wall St.

a year ago

Exploring 3 Undervalued Small Caps In United States With Insider Action

Amarin (AMRN) Stock Down Despite Q2 Earnings & Revenues Beat
AMRN

Zacks

a year ago

Amarin (AMRN) Stock Down Despite Q2 Earnings & Revenues Beat

Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript
AMRN

Motley Fool

a year ago

Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript

Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update
AMRN

GlobeNewswire

a year ago

Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update

Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?
AMRN

Zacks

a year ago

Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?

Amarin Corporation plc's (NASDAQ:AMRN) Intrinsic Value Is Potentially 29% Above Its Share Price
AMRN

Simply Wall St.

a year ago

Amarin Corporation plc's (NASDAQ:AMRN) Intrinsic Value Is Potentially 29% Above Its Share Price

AMRN

MT Newswires

a year ago

Sector Update: Health Care Stocks Edge Lower Premarket Thursday

AMRN

MT Newswires

a year ago

Amarin Says Vazkepa Secures National Reimbursement in Portugal

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal
AMRN

GlobeNewswire

a year ago

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal

Share on Social Networks: